58 related articles for article (PubMed ID: 10022794)
1. Suramin blocks hepatitis C binding to human hepatoma cells in vitro.
Garson JA; Lubach D; Passas J; Whitby K; Grant PR
J Med Virol; 1999 Mar; 57(3):238-42. PubMed ID: 10022794
[TBL] [Abstract][Full Text] [Related]
2. Host cell responses induced by hepatitis C virus binding.
Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
[TBL] [Abstract][Full Text] [Related]
3. Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.
Valli MB; Serafino A; Crema A; Bertolini L; Manzin A; Lanzilli G; Bosman C; Iacovacci S; Giunta S; Ponzetto A; Clementi M; Carloni G
J Med Virol; 2006 Feb; 78(2):192-201. PubMed ID: 16372297
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
5. STAT3 induces anti-hepatitis C viral activity in liver cells.
Zhu H; Shang X; Terada N; Liu C
Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes.
Hilgard P; Stockert R
Hepatology; 2000 Nov; 32(5):1069-77. PubMed ID: 11050058
[TBL] [Abstract][Full Text] [Related]
7. [In vitro infection of human liver cancer cell line HepG2 with HCV].
Song ZQ; Hao F; Ma QY; Wang YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):77-80. PubMed ID: 12870026
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
9. [Screening of cellular proteins binding to the core region of hepatitis C virus RNA by ultraviolet cross-linking assay].
Su HX; Zhang JX; Zhao XN; Lu J; Yan YP
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):656-9. PubMed ID: 16174452
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
Amin MA; Awadein MR; Gabr H
Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame.
Aizaki H; Harada T; Otsuka M; Seki N; Matsuda M; Li YW; Kawakami H; Matsuura Y; Miyamura T; Suzuki T
Hepatology; 2002 Dec; 36(6):1431-8. PubMed ID: 12447869
[TBL] [Abstract][Full Text] [Related]
13. A highly hydrophobic domain within hypervariable region 1 may be related to the entry of hepatitis C virus into cultured human hepatoma cells.
Kurihara C; Tsuzuki Y; Hokari R; Nakashima H; Mataki N; Kuroki M; Kawaguchi A; Nagao S; Kondo T; Miura S
J Med Virol; 2004 Dec; 74(4):546-55. PubMed ID: 15484277
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.
Choi J; Lee KJ; Zheng Y; Yamaga AK; Lai MM; Ou JH
Hepatology; 2004 Jan; 39(1):81-9. PubMed ID: 14752826
[TBL] [Abstract][Full Text] [Related]
15. Exploiting hepatitis C virus activation of NFkappaB to deliver HCV-responsive expression of interferons alpha and gamma.
Matskevich AA; Strayer DS
Gene Ther; 2003 Oct; 10(22):1861-73. PubMed ID: 14502215
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
Dou J; Liu P; Wang J; Zhang X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
[TBL] [Abstract][Full Text] [Related]
17. [Persistence of hepatitis C virus type II in patient's peripheral blood B lymphocytes transformed by Epstein-Barr virus].
Cheng J; Chen L; Tong W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):349-53. PubMed ID: 11798785
[TBL] [Abstract][Full Text] [Related]
18. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
Hofmann WP; Dries V; Herrmann E; Gärtner B; Zeuzem S; Sarrazin C
J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-HCV vector.
Fipaldini C; Bellei B; La Monica N
Virology; 1999 Mar; 255(2):302-11. PubMed ID: 10069956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
